can’t stand a sob story. This is the stock market with ups and...

can’t stand a sob story. This is the stock market with ups and downs. Mesoblast is a global leader in cellular medicines with patent protection for a long time. They haven’t been given an outright no. It wouldn’t surprise me one bit to see the stock back up as news filters through from the covid trial. We expect the results to be positive and this is a randomised trial this time. The approval for aGVHD will come. This loser posting about how she lost money and it’s the end of the world as if someone has died will look back and see MSB’s share price much higher in the future and you know what.. it will feel great knowing we don’t have investors like this holding the share. If you can’t handle the ups and downs of the market then don’t be in it.